All investors should definitely have quality investment in the Cancer therapy sector either directly or as a proxy.
Very simply. The goal of cancer treatment is to cure or shrink a cancer or stop it from spreading. Hard to make a solid case to not own some.
Many cancer treatments exist. Your cancer treatment plan may be based on your type of cancer and your situation. Today, Aprea Therapeutics is a clinical stage, platform biotechnology company focused on the development of novel, synthetic lethality-based therapies with direct on-target mechanisms of action and clear clinical pathways.
‘Lethality’ is such a great word when attempting to cure Cancer. Global Cancer Therapeutics Market size was valued at USD 136.6 Billion in 2022 and is poised to grow from USD 149.02 Billion in 2023 to USD 299.13 Billion by 2031, at a CAGR of 9.1% during the forecast period (2024-2031).
As one can see the chart above denotes a steady market that says accumulation with slight profit taking is underway.
According to Precedence Research, the global digital therapeutics market size was estimated at USD 7.88 billion in 2024 and is expected to hit around USD 56.76 billion by 2034, poised to grow at a CAGR of 21.83% from 2024 to 2034. North America contributed the largest market share of 44.03% in 2023. (2 days ago.)
Currently at USD3.20, Analysts predict increases in the neighbourhood of;
Key Level #1: $4.34 (+33.54%)
Key Level #2: $4.99 (+53.54%)
Key Level #3: $6.83 (+110.15%)
Key Level #4: $7.74 (+138.15%)
Potential Support: $2.73
52-week hi-lo.
52 Week hi-lo is USD8.50 to USD3.50. Even the frequent price pops should intrigue traders. This story and Company are the very embodiment of a dollar cost average. Besides maintaining exposure, investor with be there for natural growth, the M&A sector, and simply a way to keep apprised amend new cutting-edge therapies.
The life you save through your investment could be you own.
Or Mine.
